We are live on ! Find out more
ETCM

Evolutionary Tree Capital Management Portfolio holdings

AUM $53.2M
1-Year Est. Return 13.56%
This Fund
S&P 500
This Quarter Est. Return
-5.12%
1 Year Est. Return
+13.56%
3 Year Est. Return
+100.03%
5 Year Est. Return
+61.7%
10 Year Est. Return
AUM
$86.1M
AUM Growth
-$12.2M
Cap. Flow
-$6.24M
Cap. Flow %
-7.26%
Top 10 Hldgs %
55.5%
Holding
33
New
3
Increased
6
Reduced
19
Closed
5

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$3.88M
2
CACI icon
CACI
CACI
+$2.49M
3
CWAN
Clearwater Analytics
CWAN
+$2.37M
4
PRCT icon
Procept Biorobotics
PRCT
+$870K
5
MSFT icon
Microsoft
MSFT
+$820K

Sector Composition

Rank Sector Weight
1 Technology 45.14%
2 Consumer Discretionary 17.88%
3 Healthcare 16.17%
4 Communication Services 13.05%
5 Financials 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZS icon
26
Zscaler
ZS
$22.6B
$1.52M 1.77%
7,669
-94
-1% -$18.7K
HUBS icon
27
HubSpot
HUBS
$9.73B
$1.29M 1.5%
2,266
-3,240
-59% -$2.27M
SE icon
28
Sea Limited
SE
$60.9B
$228K 0.26%
1,745
-265
-13% -$32.9K
INSP icon
29
Inspire Medical Systems
INSP
$1.46B
-9,259
Closed -$1.72M
NTLA icon
30
Intellia Therapeutics
NTLA
$1.55B
-47,406
Closed -$553K
PANW icon
31
Palo Alto Networks
PANW
$265B
-8,976
Closed -$1.63M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.68B
-20,881
Closed -$2.54M
TTD icon
33
Trade Desk
TTD
$7.89B
-11,486
Closed -$1.35M

Similar funds

Evolutionary Tree Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Evolutionary Tree Capital Management held 33 positions worth $86.1M, down 12% from $98.3M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Evolutionary Tree Capital Management withdrew a net $6.24M in Q1 2025, closing 5 positions and reducing 19 holdings. Its most notable exit was Sarepta Therapeutics, an estimated $2.54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Evolutionary Tree Capital Management opened a new position in Synopsys worth $3.43M.

  • Evolutionary Tree Capital Management's largest Q1 2025 buy was Synopsys: 7,997 shares worth $3.43M.
  • Evolutionary Tree Capital Management added most to Procept Biorobotics in Q1 2025, an estimated $870K increase.
  • Evolutionary Tree Capital Management's biggest Q1 2025 reduction was Axon Enterprise, cutting an estimated $2.63M.
  • Evolutionary Tree Capital Management fully exited Sarepta Therapeutics in Q1 2025, selling an estimated $2.54M.
  • Evolutionary Tree Capital Management's ten largest holdings make up 55% of its $86.1M portfolio in Q1 2025.
  • Evolutionary Tree Capital Management opened 3 new positions and closed 5 in Q1 2025.
  • Evolutionary Tree Capital Management's portfolio value fell 12% quarter-over-quarter to $86.1M.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2025, filed 9 May 2025.